课题基金 / 基金详情

Eval. of Minocycline as a Microglia Inhibitor in Tx of Diabetic Macular Edema

Eval. of Minocycline as a Microglia Inhibitor in Tx of Diabetic Macular Edema
评估。
批准号:
8556863
负责人:
Frederick Ferris
金额:
$8.77万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

Frederick Ferris的其他基金

相似基金

相关文献

中文摘要
翻译
越来越多的证据表明视网膜小胶质细胞确实与糖尿病视网膜病变有关。 米诺环素是第二代四环素,其抗炎特性与其抗微生物特性分开。本研究旨在探讨米诺环素(一种小胶质细胞抑制剂)治疗糖尿病性黄斑水肿的安全性和有效性。 这是一项前瞻性、非随机、非对照、单组、单中心初步研究,旨在研究米诺环素作为小胶质细胞抑制剂在已接受标准治疗激光治疗或不适合标准治疗的DME患者中的安全性和有效性。
英文摘要
There is accumulating evidence that retinal microglia are indeed associated with diabetic retinopathy. Minocycline is a second-generation tetracycline, which has anti-inflammatory properties that are separate from its anti-microbial properties. The study objective is to investigate the safety and efficacy of minocycline, a microglia inhibitor, in the treatment of diabetic macular edema. This is a prospective, non-randomized, uncontrolled, single group, single center pilot study to investigate the safety and efficacy of minocycline as a microglia inhibitor in patients with DME who have already been treated with standard-of-care laser or who are not amenable to standard-of-care therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Internal Monitoring of Eye Movement in Schizophrenia
  • 批准号:
    8737660
  • 项目类别:
  • 资助金额:
    $2.36万
  • 财政年份:
    --
  • 负责人:
    Frederick Ferris
  • 依托单位:
SNPs in Patients with and without Diabetic Macular Edema
  • 批准号:
    8556861
  • 项目类别:
  • 资助金额:
    $9.98万
  • 财政年份:
    --
  • 负责人:
    Frederick Ferris
  • 依托单位:
Eval. of Minocycline as a Microglia Inhibitor in Tx of Diabetic Macular Edema
  • 批准号:
    8339807
  • 项目类别:
  • 资助金额:
    $16.39万
  • 财政年份:
    --
  • 负责人:
    Frederick Ferris
  • 依托单位:
Genotype - phenotype Study of Patients with Plaquenil^-induced Retinal Toxicity,
  • 批准号:
    8339806
  • 项目类别:
  • 资助金额:
    $28.52万
  • 财政年份:
    --
  • 负责人:
    Frederick Ferris
  • 依托单位:
海外基金